ARCHIVES

FDA Approives Lilly’s Alimta For 1st-Line Metastatic NSCLC

This article is from The Cancer Letter archive.

Vol. 31 No. 9 | September 26, 2008

Download PDF Visit The Full Archive

Related Articles

NCI Objects To Fisher As Scientific Director Of NSABP, Threatens To Cut Off Funding

May 6, 1994

Watson To Head Genome Research

September 30, 1988

NSABP Executive Committee Nominates Wolmark To Succeed Fisher As Chairman

October 21, 1994

Leyland-Jones Named Director of Emory’s Winship Cancer Institute

November 17, 2006

HHS Secretary Rebukes Task Force Guidelines On Breast Cancer Screening

November 29, 2009

Cooperative Groups: Group Affiliates, Statistical Offices At Top Of NCI’s Most Needy Cases List

November 13, 1998